A CASE OF DÜHRING'S DERMATITIS HERPETIFORMIS ASSOCIATED WITH SARS - COV - 2
Clinical studies during the epidemic of a new coronavirus infection caused by SARS - CoV -2 confirm not only dermatropic skin lesions, but also complex immune-mediated skin complications of COVID -19, one of which is Dühring's herpetiform dermatitis.
To present a clinical case of Dühring's dermatitis herpetiformis, which developed against the background of a coronavirus infection, probably caused by the SARS - CoV - 2 virus.
Retrospective analysis of the medical history, interpretation of clinical and laboratory data in an 81-year-old patient with developed Duhring's dermatitis herpetiformis. Characteristic changes in the skin pathological process in a patient with Dühring's dermatitis herpetiformis made it possible to assume a tendency to a protracted severe course as a result of a coronavirus infection, leading to a protracted immunodeficiency state. The presented case will be of interest to therapists, infectious disease specialists, doctors of other specialties, as well as residents and students of medical universities.
A CASE OF DÜHRING'S DERMATITIS HERPETIFORMIS
ASSOCIATED WITH SARS - COV - 2
Nurgul K. Sultanova1-2, Nurlan K. Shaimardanov1,
1 NJSC "Semey Medical University", Semey c., Republic of Kazakhstan;
2 City multidisciplinary hospital №1 of Semey city, Semey c., Republic of Kazakhstan.
1. Calvan Casas C., Catala A., Carretero Hernandez G. et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases // Br. J. Dermatol. 2020. 183:71.
2. Daneshgaran G., Dubin D.P., Gould D.J. Cutaneous Manifestations of COVID-19: An Evidence-Based Reviev // Am J Clin Dermatol. 2020. 21:627.
3. de Masson A., Bouaziz J.D., Sulimovic L. et al. Chilblains is a common cutaneous finding during the COVID-19 pandemic; A retrospective nationwide study from France // J. Am. Acad. Dermatol. 2020. 83:667.
4. Freeman E.E., McMahon D.E., Lipoff J.B. et al. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries // J Am Acad Dermatol. 2020. 83:486.
5. Freeman E.E., McMahon D.E., Fitzgerald M.E. et al. The American Academy of Dermatology COVID-19 registry: Crowdsoursing dermatology COVID-19 // J Am Acad Dermatol. 2020. 83:509.
6. Guan W.J., Ni Z.Y., Hu Y. et al. Clinical Characteristics of Cutaneous Disease 2019 in China // N Engl J Med. 2020. 382:1708.
7. Madigan L.M., Micheletti R.G., Shinkai K. How Dermatologists Can learn and Contribute at the Leading Edge of the COVID-19 Global Pandemic // JAMA Dermato.l 2020. 156:733.
8. Marzano A.V., Genovese G., Moltrasio C. et al. The clinical spectrum of COVID-19 associated cutaneous manifestations: An Italian multicenter study of 200 adult patients // JAM Acad Dermatol. 2021. 84:1356.
9. Mascitti H., Jourdain P., Bleibtreu A. et al. Prognosis of rash and chilblain-like lesions among outpatientswith COVID -19: a large cohort study // Eur J Clin Microbiol Infect Dis. 2021. 40:2243.
10. Rajan M.B., Kumar M.P., Bhardwaj A. The trend of cutaneous lesions during COVID-19 pandemic: lessons from a meta-analysis and systematic review // Int J Dermatol. 2020. 59:1358.
11. Recalcati S., Gianotti R., Fantini F. COVID-19: The experience from Itali // Clin Dermatol. 2021. 39:12.
12. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective // J Eur Acad Dermatol Venerol. 2020. 34:e 212.
13. Sameni F., Hajikhani B., Yaslianifard S. et al. COVID-19 and Skin Manifestations: An Overview of case Reports / Case Series and Meta-Analysis of Prevalence Studies // Front Med (Lausanne). 2020. 7:573188.
14. Sugai T., Fujita Y., Inamura E. et al. Prevalence and patterns of cutaneous manifestations in 1245 COVID-19 patients in Japan a single- ctntre study // J EUR Acad Dermatol Venerol. 2022. 36:e522.
15. Tan S.W., Tam Y.C., Oh C.C. Skin manifestationsof COVID-19: A worldwide review // JAAD Int 2021. 2:119.
16. Visconti A., Bataille V., Rossi N. et al. Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection // Br J Dermatol. 2021. 184:880.
17. Visconti A., Murray B., Rossi N. et al. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in348 691 UK users of the UK ZOE COVID Study app // Br J Dermatol. 2022. 187:900.
Number of Views: 65
Category of articles:
Clinical case
Bibliography link
Sultanova N.K., Shaimardanov N.K. A case of Dühring's dermatitis herpetiformis associated with SARS - CoV -2 // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 4, pp. 278-281. doi 10.34689/SH.2023.25.4.034Related publications:
RABIES - AN INFECTIOUS DISEASE WITH A FATAL OUTCOME (CLINICAL CASE)
ACTIVATION OF OPPOSITE PROCESSES – OSTEOPOROSIS AND OSTEOGENESIS IN ANKYLOSING SPONDYLITIS USING THE CLINICAL CASES
GRANULOMATOUS POLYANGITIS (WEGENER’S GRANULOMATOSIS) IN THE PRACTICE OF A RHEUMATOGIST
VARIANT OF ADULT-ONSET STILL’SDISCASE: CASE REPORT
A CASE OF DÜHRING'S DERMATITIS HERPETIFORMIS ASSOCIATED WITH SARS - COV - 2